Inventor
BERNETT MATTHEW J
US55 patents
⚠️ This page may combine multiple inventors who share the name “BERNETT MATTHEW J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
XENCOR INC
41 patentsUS9856327B2Jan 2, 2018
Heterodimeric antibodies to CD3 X CD123
XENCOR INC72 citations98
US9701759B2Jul 11, 2017
Heterodimeric proteins
XENCOR INC48 citations98
US9605061B2Mar 28, 2017
Antibodies with modified isoelectric points
XENCOR INC43 citations98
US11225528B2Jan 18, 2022
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC11 citations94
US10526417B2Jan 7, 2020
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC27 citations94
US10259887B2Apr 16, 2019
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC25 citations94
US9850320B2Dec 26, 2017
Heterodimeric antibodies to CD3 X CD20
XENCOR INC13 citations92
US9617348B2Apr 11, 2017
Compositions and methods for treating IgE-mediated disorders
XENCOR INC11 citations92
US9266966B2Feb 23, 2016
Compositions and methods for treating IgE-mediated disorders
XENCOR INC8 citations92
US9221916B2Dec 29, 2015
Compositions and methods for treating IgE-mediated disorders
XENCOR INC12 citations92
US11505595B2Nov 22, 2022
TIM-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and TIM-3 antigen binding domains
XENCOR INC9 citations86
US10738132B2Aug 11, 2020
Heterodimeric proteins
XENCOR INC9 citations84
US10155800B2Dec 18, 2018
CTLA4-Ig immunoadhesins
XENCOR INC7 citations84
US9371397B2Jun 21, 2016
CTLA4-Ig immunoadhesins
XENCOR INC7 citations84
US11084863B2Aug 10, 2021
Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains
XENCOR INC7 citations83
US9803020B2Oct 31, 2017
Optimized antibodies that target CD19
XENCOR INC5 citations83
US9540451B2Jan 10, 2017
Compositions and methods for treating IgE-mediated disorders
XENCOR INC8 citations83
US11618776B2Apr 4, 2023
Targeted heterodimeric Fc fusion proteins containing IL-15/IL-15RA and NKG2D antigen binding domains
XENCOR INC4 citations75
US11945880B2Apr 2, 2024
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US11859011B2Jan 2, 2024
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US11352412B2Jun 7, 2022
CTLA4-IG immunoadhesins
XENCOR INC2 citations73
US11352442B2Jun 7, 2022
Heterodimeric antibodies that bind CD3 and CD38
XENCOR INC2 citations73
US11254727B2Feb 22, 2022
CTLA4-Ig immunoadhesins
XENCOR INC2 citations73
US10913803B2Feb 9, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC1 citations73
US10889653B2Jan 12, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC2 citations73
US10858451B2Dec 8, 2020
Bispecific antibodies that bind to CD38 and CD3
XENCOR INC2 citations73
US10851178B2Dec 1, 2020
Heterodimeric human IgG1 polypeptides with isoelectric point modifications
XENCOR INC2 citations73
US11618788B2Apr 4, 2023
Optimized antibodies that target CD19
XENCOR INC2 citations72
US11566080B2Jan 31, 2023
Compositions and methods for treating IgE-mediated disorders
XENCOR INC2 citations72
US10626182B2Apr 21, 2020
Optimized antibodies that target CD19
XENCOR INC1 citations72
US12509495B2Dec 30, 2025
LAG-3 targeted heterodimeric fusion proteins containing IL-15/IL-15RA Fc-fusion proteins and LAG-3 antigen binding domains
XENCOR INC1 citations64
US12559572B2Feb 24, 2026
Compositions and methods for treating IgE-mediated disorders
XENCOR INC0 citations62
US12486311B2Dec 2, 2025
CTLA4-Ig immunoadhesins
XENCOR INC0 citations62
US12448423B2Oct 21, 2025
Targeted heterodimeric Fc fusion proteins containing NKG2D antigen binding domains
XENCOR INC0 citations62
US11673972B2Jun 13, 2023
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US11111315B2Sep 7, 2021
Heterodimeric antibodies that bind CD3 and tumor antigens
XENCOR INC0 citations62
US12398207B2Aug 26, 2025
Heterodimeric antibodies that bind CD3 and CLDN6
XENCOR INC1 citations61
US12139525B2Nov 12, 2024
Targeted heterodimeric Fc fusion proteins containing IL-15 IL-15alpha and antigen binding domains
XENCOR INC0 citations61
US11512122B2Nov 29, 2022
IL-7-FC-fusion proteins
XENCOR INC0 citations61
US11859012B2Jan 2, 2024
Heterodimeric antibodies that bind CD3 and GPC3
XENCOR INC0 citations60
US7592423B2Sep 22, 2009
Globular adiponectin variants
XENCOR INC4 citations60
BERNETT MATTHEW J
4 patentsUS8524867B2Sep 3, 2013
Optimized antibodies that target CD19
BERNETT MATTHEW J56 citations96
US8551485B2Oct 8, 2013
Anti-CD40 antibodies and methods of inhibiting proliferation of CD40 expressing cells
BERNETT MATTHEW J45 citations93
US8314213B2Nov 20, 2012
Human equivalent monoclonal antibodies engineered from nonhuman variable regions
BERNETT MATTHEW J36 citations92
US8394374B2Mar 12, 2013
Optimized antibodies that target HM1.24
BERNETT MATTHEW J4 citations60
LAZAR GREGORY A
2 patentsDAHIYAT BASSIL I
1 patentDESJARLAIS JOHN R
1 patentDESJARLAIS JOHN
1 patentShowing the top 50 of 55 patents by PatentIndex Score.